Geneious provides an AI‑enhanced, cloud‑based bioinformatics suite that unifies molecular modeling, sequence analysis, wet‑lab data integration, and antibody registration into a single platform.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers in molecular biology and antibody discovery often face fragmented tools, cumbersome data management, and high computational complexity when analyzing large sequence datasets, slowing experimental progress.
Solution
Geneious offers an AI‑enhanced, cloud‑based bioinformatics suite that integrates molecular modeling, sequence analysis, wet‑lab data integration, and antibody registration into a single platform. The software automates routine computational tasks, provides intuitive visualization, and centralizes data storage, allowing scientists to focus on experimental design and interpretation. By delivering end‑to‑end functionality for antibody screening and analysis, Geneious reduces the time and expertise required to move from raw sequence data to actionable insights.
Target Audience
Primary users are scientists and bioinformaticians in universities, research institutes, and biotech or pharmaceutical companies engaged in antibody research and molecular biology projects.
Features
- AI‑driven sequence alignment, annotation, and variant analysis optimized for antibody discovery workflows
- Integrated molecular modeling tools for structure prediction and affinity optimization
- Seamless wet‑lab data import and registration modules that link experimental results to computational analyses
- Cloud‑hosted environment with collaborative project workspaces and centralized data management
- Interactive visualizations for sequence comparison, phylogenetics, and epitope mapping
- Compatibility with common bioinformatics file formats and APIs for external tool integration